Manulife (Manufacturers Life Insurance)
RARX

Manulife (Manufacturers Life Insurance)’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,333
Closed -$1.07M – 3024
2020
Q1 		$1.07M Buy
22,333
+1,345
+6% +$62.6K ﹤0.01% 1493
2019
Q4 		$985K Sell
20,988
-96
-0.5% -$4.24K ﹤0.01% 1690
2019
Q3 		$506K Buy
21,084
+1,644
+8% +$48.7K ﹤0.01% 2007
2019
Q2 		$585K Buy
+19,440
New +$445K ﹤0.01% 1953
2018
Q3 		– Sell
-714
Closed -$7K – 4165
2018
Q2 		$7K Hold
714
– – ﹤0.01% 4021
2018
Q1 		$4K Sell
714
-2,399
-77% -$17.1K ﹤0.01% 4177
2017
Q4 		$26K Sell
3,113
-8,144
-72% -$100K ﹤0.01% 3730
2017
Q3 		$165K Buy
11,257
+397
+4% +$6K ﹤0.01% 3129
2017
Q2 		$204K Buy
10,860
+2,543
+31% +$57.4K ﹤0.01% 2991
2017
Q1 		$178K Buy
8,317
+6,097
+275% +$117K ﹤0.01% 2910
2016
Q4 		$34K Buy
+2,220
New +$30.2K ﹤0.01% 3507

Other funds holding RARX

Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s RARX Position: Q2 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 22,333 shares — an estimated $1.07M sold.

Manulife (Manufacturers Life Insurance) first reported a position in RARX in Q4 2016 and held it in 11 quarters. The position peaked at $1.07M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 22,333 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $1.07M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 11 quarters.
  • Manulife (Manufacturers Life Insurance)'s Ra Pharmaceuticals, Inc. Common Stock position peaked at $1.07M in Q1 2020.
  • 1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2020, filed 10 Aug 2020.